Insider purchases - Last 6 months | Shares | Trans |
---|---|---|
Purchases | 0 | 0 |
Sales | N/A | 0 |
Net shares purchased (sold) | 0 | 0 |
Total insider shares held | 2.72M | N/A |
% net shares purchased (sold) | N/A | N/A |
Net institutional purchases - Prior quarter to latest quarter | Shares |
---|---|
Net shares purchased (sold) | N/A |
% change in institutional shares held | N/A |
Insider | Transaction | Type | Value | Date | Shares |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 2.21 per share. | Indirect | 4,095,130 | 06 Jan 2023 | 1,853,000 |
SEIDEL-DUGAN CYNTHIA PH.D. | Conversion of Exercise of derivative security at price 1.56 - 4.77 per share. | Direct | 111,838 | 12 Jan 2022 | 39,731 |
LEONARD REID | Conversion of Exercise of derivative security at price 1.56 per share. | Direct | 21,999 | 30 Dec 2021 | 14,102 |
LEONARD REID | Sale at price 13.39 - 13.97 per share. | Indirect | 40,242 | 15 Dec 2021 | 3,000 |
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 12.75 - 13.37 per share. | Indirect | 4,129,398 | 16 Jun 2021 | 323,298 |
EVNIN LUKE BASIL | Purchase at price 16.00 per share. | Indirect | 2,412,784 | 04 May 2021 | 150,799 |
EVNIN LUKE BASIL | Indirect | 04 May 2021 | 3,671,965 | ||
HBM HEALTHCARE INVESTMENTS CAYMAN LTD | Direct | 04 May 2021 | 625,995 | ||
GADICKE ANSBERT S. | Purchase at price 16.00 per share. | Indirect | 3,920,000 | 04 May 2021 | 245,000 |
GADICKE ANSBERT S. | Indirect | 04 May 2021 | 5,965,775 | ||
UPMC | Direct | 04 May 2021 | 1,097,756 | ||
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 16.00 per share. | Indirect | 27,440,000 | 04 May 2021 | 1,715,000 |
RA CAPITAL MANAGEMENT, L.P. | Indirect | 04 May 2021 | 2,253,583 | ||
FLYNN JAMES E | Purchase at price 16.00 per share. | Indirect | 12,800,000 | 04 May 2021 | 800,000 |
FLYNN JAMES E | Indirect | 04 May 2021 | 1,752,787 | ||
MPM BIOVENTURES 2014,L.P. | Purchase at price 16.00 per share. | Indirect | 2,012,144 | 04 May 2021 | 125,759 |
MPM BIOVENTURES 2014,L.P. | Indirect | 04 May 2021 | 3,062,239 | ||
LAZARUS ALON | Purchase at price 16.00 per share. | Indirect | 6,400,000 | 04 May 2021 | 400,000 |
LAZARUS ALON | Indirect | 04 May 2021 | 1,646,634 | ||
ASANUMA SAKAE | Purchase at price 16.00 per share. | Indirect | 5,000,000 | 04 May 2021 | 312,500 |
ASANUMA SAKAE | Indirect | 04 May 2021 | 1,756,409 | ||
ARKIN BIO VENTURES 2, LP. | Purchase at price 16.00 per share. | Indirect | 6,400,000 | 04 May 2021 | 400,000 |
ARKIN BIO VENTURES 2, LP. | Indirect | 04 May 2021 | 1,646,634 | ||
SPHERA GLOBAL HEALTHCARE MANAGEMENT LP | Purchase at price 16.00 per share. | Indirect | 7,600,000 | 04 May 2021 | 475,000 |
SPHERA GLOBAL HEALTHCARE MANAGEMENT LP | Indirect | 04 May 2021 | 312,997 | ||
TAIHO VENTURES, LLC | Purchase at price 16.00 per share. | Direct | 5,000,000 | 04 May 2021 | 312,500 |
TAIHO VENTURES, LLC | Direct | 04 May 2021 | 1,756,409 | ||
LONGWOOD FUND III GP, LLC | Purchase at price 16.00 per share. | Indirect | 4,000,000 | 04 May 2021 | 250,000 |
LONGWOOD FUND III GP, LLC | Indirect | 04 May 2021 | 1,427,082 |